National Institute of Pharmaceutical Education and Research, S.A.S. Nagar

What is National Institute of Pharmaceutical Education and Research, S.A.S. Nagar?

The National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (NIPER Mohali) is a government, fully residential postgraduate and research institute in Mohali, Punjab, declared an "Institute of National Importance" by an Act of Parliament (the NIPER Act, 1998) on 26 June 1998. It is an autonomous body functioning under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, and was the very first NIPER established in the country. Located about 250 km north of Delhi on a 130-acre campus, NIPER Mohali is widely regarded as India's premier pharmaceutical sciences institute and the lead campus of the seven-institute NIPER network (Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli being the others). It is best known for masters and doctoral research across medicinal chemistry, pharmaceutics, pharmacology, biotechnology and pharmaceutical management, and for ranking among the top pharmacy institutions in the NIRF rankings every year.

National Institute of Pharmaceutical Education and Research, S.A.S. Nagar Key Facts (2026)

The table below summarises the core identity of NIPER Mohali at a glance, answering the most common first question an aspirant asks: what kind of institution is it, when was it set up, and how is it recognised. Read the "Parameter" column for the attribute and the "Detail" column for NIPER Mohali's specific value. These are the foundational facts that frame everything else on this page, from rankings to fees. All figures reflect the institute's status as of the 2026 admission cycle.

The single most important takeaway is that NIPER Mohali is a government institute of national importance, not a private or affiliated college, which is why its tuition is heavily subsidised and its admission is centralised through NIPER JEE. Its consistent presence near the top of the NIRF Pharmacy list (#9 in 2025) confirms its research-led reputation. For an applicant, this means NIPER Mohali is a credentialed, research-first destination rather than a teaching-only undergraduate college.

Why Choose National Institute of Pharmaceutical Education and Research, S.A.S. Nagar?

NIPER Mohali stands apart for reasons that are specific to this institute and difficult to replicate elsewhere in Indian pharmacy education:

• Top-tier NIRF standing: NIPER Mohali was ranked #9 in the NIRF Pharmacy 2025 rankings with a score of 70.96, keeping it firmly inside India's top pharmacy institutions.
• Institute of National Importance pedigree: As the first NIPER (1998) and the lead campus of the seven-institute network, it carries statutory recognition under the NIPER Act and reports directly to the Ministry of Chemicals and Fertilizers.
• Research-first, PG-only model: The institute offers no undergraduate degrees; every programme (M.Pharm, M.S., M.Tech, MBA and PhD) is geared toward research and industry, with disciplines spanning medicinal chemistry, pharmaceutics, pharmacology, biotechnology and pharmacoinformatics.
• Strong industry recruiters: The 2025 placement cycle drew core pharma and biotech employers including Pfizer, Novartis, Zydus, Dr. Reddy's, Syngene, Biocon, Lupin and Himalaya.
• Healthy placement conversion: NIPER Mohali placed 79.00% of eligible students in 2025, up from 76.90% in 2024, with the top package reaching ₹15,00,000 (₹15 LPA) in 2025.
• Subsidised government fees: Flagship masters programmes such as M.Pharm cost around ₹96,956, a fraction of comparable private pharmacy schools, thanks to the institute's government status.

Courses, Fees & Rankings at a Glance

NIPER Mohali offers four postgraduate routes plus a doctoral programme, each admitting through NIPER JEE alongside a national qualifying exam. The table below lists each flagship programme with its total indicative fee, duration and the entrance exams accepted, then maps them against the institute's headline NIRF Pharmacy 2025 rank of #9. Use it to compare cost and entry requirements across programmes before opening the detailed Courses and Admission tabs. All fees are total programme fees drawn from our verified institutional data for the 2026 cycle.

The clearest pattern here is the value of the M.Pharm at roughly ₹96,956 total, which is the most affordable entry point and the institute's signature research degree. The MBA (Pharm) is the costliest at ₹5,75,000 but is the only route that also accepts CAT and GMAT scores, widening access for management aspirants. Across every programme, the constant is NIPER JEE, so an applicant's preparation should centre on that exam regardless of the degree chosen. For seat-level detail and specialisation lists, consult the dedicated Courses and Admission tabs.

Placement & Admission Snapshot

NIPER Mohali placed 79.00% of its eligible postgraduate students in 2025 with a highest package of ₹15,00,000 (₹15 LPA), and the headline admission route is the national NIPER JEE entrance exam combined with a GPAT/GATE/NET qualification for most masters programmes. The table below compares the institute's placement performance across 2025 and 2024 so applicants can read the direction of travel. The institute does not publicly disclose a single official average CTC figure, so this snapshot leads with the verified highest package and placement-percentage data from our records.

Both headline indicators improved year over year: the highest package rose from ₹12 LPA in 2024 to ₹15 LPA in 2025, and the placement rate climbed from 76.90% to 79.00%, signalling strengthening demand for NIPER Mohali graduates in R&D, regulatory and biotech roles. For an applicant, the practical message is that admission hinges almost entirely on cracking NIPER JEE, while strong placement conversion makes the two-year investment, especially the low-fee M.Pharm, a compelling return.

Frequently Asked Questions: National Institute of Pharmaceutical Education and Research, S.A.S. Nagar Overview 2026

Is NIPER Mohali a good institute?

Yes, NIPER Mohali is one of India's best pharmacy institutes, ranked #9 in NIRF Pharmacy 2025 with a score of 70.96. As the first NIPER (established 1998) and an Institute of National Importance under the Ministry of Chemicals and Fertilizers, it offers research-led postgraduate education, subsidised government fees and a 79.00% placement rate in 2025. Its consistent NIRF standing and recruiter list of Pfizer, Novartis and Dr. Reddy's confirm a strong reputation.

What is NIPER Mohali known for?

NIPER Mohali is known for being India's premier pharmaceutical research institute and the lead campus of the seven-institute NIPER network. Established in 1998 as an Institute of National Importance, it specialises in postgraduate and doctoral research across medicinal chemistry, pharmaceutics, pharmacology, biotechnology and pharmacoinformatics. It is also recognised for its NIRF Pharmacy 2025 rank of #9 and its strong industry placements with leading pharma and biotech employers.

What courses does NIPER Mohali offer?

NIPER Mohali offers postgraduate and doctoral programmes only: M.Pharm, M.S. (Pharm), M.Tech (Pharm), MBA (Pharm) and PhD. The M.Pharm, M.Tech and MBA are each two-year full-time programmes, while the PhD runs three years and above. Specialisations span medicinal chemistry, pharmaceutics, pharmacology and toxicology, biotechnology, pharmacoinformatics and pharmaceutical management. The institute does not offer any undergraduate (B.Pharm) degree.

What is the total fee at NIPER Mohali?

Total programme fees at NIPER Mohali range from about ₹96,956 for the M.Pharm to ₹5,75,000 for the MBA (Pharm). The M.Tech (Pharm) costs around ₹2,04,000 and the PhD around ₹3,93,000, all for the full programme duration. Because NIPER Mohali is a government Institute of National Importance, its fees are heavily subsidised compared with private pharmacy colleges, making the M.Pharm in particular an exceptionally affordable research degree.

What is the NIRF and NAAC status of NIPER Mohali?

NIPER Mohali is ranked #9 in the NIRF Pharmacy 2025 rankings with a score of 70.96, keeping it among India's top pharmacy institutions. It holds the legal status of an Institute of National Importance under the NIPER Act, 1998, and operates as an autonomous body under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Its degree-granting authority derives from this statutory recognition rather than from university affiliation.

What is the average package at NIPER Mohali?

NIPER Mohali recorded a highest package of ₹15,00,000 (₹15 LPA) in 2025, up from ₹12,00,000 (₹12 LPA) in 2024, with 79.00% of eligible students placed in 2025 versus 76.90% in 2024. The institute does not publish a single official average CTC, but top recruiters include Pfizer, Novartis, Zydus, Dr. Reddy's, Syngene, Biocon, Lupin and Himalaya, hiring across R&D, regulatory and analytical roles.

Is admission to NIPER Mohali merit-based or entrance-based?

Admission to NIPER Mohali is entrance-based, primarily through the national NIPER JEE. For most masters programmes, candidates must additionally have qualified GPAT, GATE or NET; the M.Pharm requires B.Pharm with at least 60% (or 6.75 CGPA), while the MBA (Pharm) also accepts CAT and GMAT scores. Final selection combines the entrance score with an interview, so there is no direct merit-only or management-quota route.